Juan Du
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Juan Du has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Chunhui Wan
Precision Medical Center, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication- Han Xiao
Huazhong University of Science and Technology
1 shared publication Hui Liu
Department of Neonatology, TaiHe Hospital, Hubei University of Medicine, Shiyan, Hubei, China
1 shared publicationHui Lu
Institute of Maternal and Child Health, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
1 shared publicationJia-Lu Feng
Department of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China
1 shared publicationJing Wang
State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China
1 shared publication
Latest Publications
- Open Access
- 2 March 2026
- Published by Springer Nature in BMC Genomics
- Vol. 27 (1)
Parkin-mediated ubiquitination of hif-α modulates hypoxia signaling in Megalobrama amblycephala
Megalobrama amblycephala is an economically important fish species in Chinese aquaculture, but its high sensitivity to hypoxia poses a major challenge for
- 2 March 2026
- Published by Springer Nature in BMC Genomics
- Vol. 27 (1)
Open AccessParkin-mediated ubiquitination of hif-α modulates hypoxia signaling in Megalobrama amblycephala
Megalobrama amblycephala is an economically important fish species in Chinese aquaculture, but its high sensitivity to hypoxia poses a major challenge for
- Open Access
- 24 February 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1532564
Engineered exosomes restore miR-508-5p expression in uterine corpus endometrial carcinoma and reduce tumor progression and metastasis by targeting DLL3
Introduction: Endometrial cancer (EC) is a growing global health concern. Understanding the molecular mechanisms driving EC is crucial for developing effective diagnostic and therapeutic strategies. This study investigates the roles of DLL3 and miR-508-5p in EC progression and explores a therapeutic approach using engineered exosomes to modulate their expression.Methods: TCGA data were analyzed, in vitro and in vivo experiments were performed to assess DLL3 and miR-508-5p function, and bioinformatics was used to confirm their interaction. Mesenchymal stem cells (MSCs) were engineered to produce miR-508-5p-overexpressing exosomes, and their therapeutic effects were tested in mouse models.Results: Elevated DLL3 and downregulated miR-508-5p were observed in EC and correlated with poor outcomes. miR-508-5p directly targets DLL3. Engineered exosomes restored miR-508-5p, inhibited DLL3, and reduced tumor growth and metastasis in mouse models.Discussion: The findings highlight the roles of DLL3 and miR-508-5p in EC. Targeting the miR-508-5p/DLL3 axis via exosome-mediated delivery represents a promising therapeutic strategy for EC.
- 24 February 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1532564
Open AccessEngineered exosomes restore miR-508-5p expression in uterine corpus endometrial carcinoma and reduce tumor progression and metastasis by targeting DLL3
Introduction: Endometrial cancer (EC) is a growing global health concern. Understanding the molecular mechanisms driving EC is crucial for developing effective diagnostic and therapeutic strategies. This study investigates the roles of DLL3 and miR-508-5p in EC progression and explores a therapeutic approach using engineered exosomes to modulate their expression.Methods: TCGA data were analyzed, in vitro and in vivo experiments were performed to assess DLL3 and miR-508-5p function, and bioinformatics was used to confirm their interaction. Mesenchymal stem cells (MSCs) were engineered to produce miR-508-5p-overexpressing exosomes, and their therapeutic effects were tested in mouse models.Results: Elevated DLL3 and downregulated miR-508-5p were observed in EC and correlated with poor outcomes. miR-508-5p directly targets DLL3. Engineered exosomes restored miR-508-5p, inhibited DLL3, and reduced tumor growth and metastasis in mouse models.Discussion: The findings highlight the roles of DLL3 and miR-508-5p in EC. Targeting the miR-508-5p/DLL3 axis via exosome-mediated delivery represents a promising therapeutic strategy for EC.
- Open Access
- 24 January 2025
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 16, 1469610
Identification of key genes underlying radiosensitivity and radioresistance in endometrial cancer through integrated bioinformatics analysis
Introduction: Radiation therapy is crucial in the treatment of endometrial cancer (UCEC). Patients exhibit significant variability in radiosensitivity, affecting therapeutic effect. Scarcity of studies exploring the gene-radiosensitivity relationship based on clinical data. Underlying molecular mechanisms of radiosensitivity and radioresistance require further investigation.Methods: Study aimed to reveal molecular mechanisms underlying radiosensitivity and radioresistance in UCEC patients. Included 12 radiosensitive and 20 radioresistant UCEC samples. Conducted differential expression analysis to screen for significantly different genes between groups. Applied Lasso regression and randomized survival forest model to identify key genes. Performed functional annotation, correlation analysis, and survival analysis on key genes.Results: Key genes positively correlated with UCEC tumorigenesis-related genes in the radioresistant group. Reduction in the proportion of Macrophages.M0 observed in the radioresistant group, associated with poor prognosis. GO and GSVA analyses revealed biological processes and signaling pathways involved in key genes. High expression of MARCKS, MACC1, and GRB10 correlated with poorer survival rates. High expression of NINJ2 correlated with higher survival rates and higher sensitivity to radiation therapy.Discussion: Study contributes to a deeper understanding of UCEC radiosensitivity. Provides theoretical support for the development of personalized radiotherapy regimens in clinical practice. Potential to improve prognosis and quality of life of patients.
- 24 January 2025
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 16, 1469610
Open AccessIdentification of key genes underlying radiosensitivity and radioresistance in endometrial cancer through integrated bioinformatics analysis
Introduction: Radiation therapy is crucial in the treatment of endometrial cancer (UCEC). Patients exhibit significant variability in radiosensitivity, affecting therapeutic effect. Scarcity of studies exploring the gene-radiosensitivity relationship based on clinical data. Underlying molecular mechanisms of radiosensitivity and radioresistance require further investigation.Methods: Study aimed to reveal molecular mechanisms underlying radiosensitivity and radioresistance in UCEC patients. Included 12 radiosensitive and 20 radioresistant UCEC samples. Conducted differential expression analysis to screen for significantly different genes between groups. Applied Lasso regression and randomized survival forest model to identify key genes. Performed functional annotation, correlation analysis, and survival analysis on key genes.Results: Key genes positively correlated with UCEC tumorigenesis-related genes in the radioresistant group. Reduction in the proportion of Macrophages.M0 observed in the radioresistant group, associated with poor prognosis. GO and GSVA analyses revealed biological processes and signaling pathways involved in key genes. High expression of MARCKS, MACC1, and GRB10 correlated with poorer survival rates. High expression of NINJ2 correlated with higher survival rates and higher sensitivity to radiation therapy.Discussion: Study contributes to a deeper understanding of UCEC radiosensitivity. Provides theoretical support for the development of personalized radiotherapy regimens in clinical practice. Potential to improve prognosis and quality of life of patients.